Massar Capital Management LP bought a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,426 shares of the medical instruments supplier's stock, valued at approximately $532,000.
A number of other large investors have also added to or reduced their stakes in the company. Barclays PLC increased its holdings in shares of ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock valued at $10,790,000 after acquiring an additional 8,010 shares in the last quarter. Franklin Resources Inc. increased its stake in ICU Medical by 99.3% during the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock valued at $2,111,000 after purchasing an additional 5,834 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after buying an additional 25,031 shares during the last quarter. Diversified Trust Co lifted its stake in shares of ICU Medical by 32.3% during the fourth quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier's stock worth $512,000 after buying an additional 805 shares during the period. Finally, Inspire Investing LLC grew its holdings in shares of ICU Medical by 13.2% during the fourth quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier's stock valued at $404,000 after buying an additional 303 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.
ICU Medical Price Performance
ICUI stock traded down $1.50 during trading on Friday, hitting $135.66. The stock had a trading volume of 164,550 shares, compared to its average volume of 273,236. The company's 50-day moving average price is $143.81 and its two-hundred day moving average price is $158.23. ICU Medical, Inc. has a twelve month low of $94.19 and a twelve month high of $196.26. The stock has a market capitalization of $3.33 billion, a P/E ratio of -29.68 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.
Analysts Set New Price Targets
A number of brokerages recently commented on ICUI. StockNews.com lowered ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Raymond James set a $97.00 target price on shares of ICU Medical in a research note on Wednesday, March 12th. KeyCorp dropped their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday. Finally, Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $162.67.
View Our Latest Stock Report on ICU Medical
ICU Medical Company Profile
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Read More

Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.